Biotech and Pharma Industry News | BioPharma Dive
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA …
Novo Holdings’ purchase of Catalent set to close after regulators ...
2024年12月16日 · The Federal Trade Commission declined to challenge the deal before a deadline passed, allowing the companies to move ahead with the $16.5 billion acquisition. …
The top biopharma conferences in 2025 | BioPharma Dive
2024年10月1日 · American Association of Cancer Research Annual Meeting. April 25 - 30, 2025 Chicago. While the American Society of Clinical Oncology’s meeting often gets billed as the …
Biotech startups are built on venture capital. Track funding rounds ...
2024年11月21日 · Drug development is an expensive, risky endeavor. Biotechnology companies just starting out are many years away from seeing profits, if ever. So more often than not, a …
Scholar Rock scores with ‘surprise’ success in SMA drug study
2024年10月7日 · Dive Brief: An experimental, muscle-preserving therapy from Scholar Rock succeeded in a Phase 3 trial in spinal muscular atrophy, positioning the biotechnology …
Drugmakers are racing to find the next Wegovy. These obesity …
2024年10月10日 · Within the pharmaceutical industry, a multibillion-dollar race is underway to top Novo Nordisk’s and Eli Lilly’s in-demand obesity drugs. Dozens of companies, large and small, …
Biotech IPOs are the industry’s lifeblood. Track how they’re …
4 天之前 · Initial public offerings make the biotechnology industry tick. Stock listings give young companies the funding they need to develop their drugs, and their venture backers an …
Wave sees RNA editing validation in early trial results
2024年10月16日 · According to the company, this kind of effect hasn’t before been demonstrated in clinical testing. “Achieving the first-ever therapeutic RNA editing in humans is a significant …
AbbVie to acquire a J&J-backed brain drugmaker for $1.4B
2024年10月28日 · AbbVie has agreed to acquire a young company with drugmaking technology from Johnson & Johnson and an experimental treatment for Alzheimer’s disease that’s in the …
Drug patents protect pharma profits. Track when they’ll expire.
2024年5月8日 · Patents reward drugmakers for their inventions and, effectively, the large sums of money they invest in research and development. The legal monopoly that patents provide …